Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug aims to slow kidney damage in diabetes and rare diseases

NCT ID NCT06466135

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study tests an experimental drug called WAL0921 in 96 adults with kidney diseases that cause protein in the urine, including diabetic nephropathy and several rare conditions. Participants receive either the drug or a placebo as an IV infusion every two weeks for 14 weeks, then are monitored for 24 more weeks. The goal is to see if the drug is safe and can reduce protein leakage and protect kidney function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 96 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults, age 18-75 years * Diagnosis of one of the following glomerular kidney diseases: diabetic nephropathy; primary focal segmental glomerulosclerosis; treatment resistant-minimal change disease; primary IgA nephropathy; primary membranous nephropathy * eGFR greater than or equal to 30 mL/min/1.73 m2 Exclusion Criteria: * Currently pregnant or planning to become pregnant * History of organ transplantation * History of alcohol or substance use disorder * Acute dialysis or acute kidney injury within 6 months of Screening * Any prior or current medical condition that, in the judgment of the Investigator, would prevent the subject from safely participating in and/or completing all study requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic nephropathies are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    32 sites in 6 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • AIIMS Hospital

    ACTIVE_NOT_RECRUITING

    Raipur, Chhattisgarh, 492099, India

  • Academic Medical Research Institute

    RECRUITING

    Los Angeles, California, 90022, United States

  • Ajou University Hospital

    RECRUITING

    Suwon, 16499, South Korea

  • Barts Health NHS Trust

    WITHDRAWN

    London, E1 2ES, United Kingdom

  • Clinical Advancement Center

    RECRUITING

    San Antonio, Texas, 78212, United States

  • Clinical Trial Network

    RECRUITING

    Houston, Texas, 77074, United States

  • College of Life Sciences, University of Leicester

    RECRUITING

    Leicester, LE1 7RH, United Kingdom

    Contact Email: •••••@•••••

  • Colorado Kidney and Vascular Care

    RECRUITING

    Denver, Colorado, 80012, United States

  • D & H Tamarac Research Center

    RECRUITING

    Tamarac, Florida, 33321, United States

  • Dhiraj Hospital

    ACTIVE_NOT_RECRUITING

    Vadodara, Gujarat, 391760, India

  • Dunes Clinical Research

    RECRUITING

    Dakota Dunes, South Dakota, 57049, United States

  • Fides Clinical Research

    RECRUITING

    Atlanta, Georgia, 30342, United States

  • Hallym University Sacred Heart Hospital

    RECRUITING

    Anyang, 14068, South Korea

  • Hospital Canselor Tuanku Muhriz UKM

    RECRUITING

    Cheras, Kuala Lumpur, 56000, Malaysia

  • Hospital Kuala Lumpur

    RECRUITING

    Kuala Lumpur, Kuala Lumpur, 50586, Malaysia

  • Hospital Sultan Idris Shah Serdang

    RECRUITING

    Kajang, Selangor, 43000, Malaysia

  • Hospital Tengku Ampuan Afzan

    RECRUITING

    Kuantan, Pahang, 25100, Malaysia

  • Jaffna Teaching Hospital

    NOT_YET_RECRUITING

    Jaffna, 40000, Sri Lanka

  • Kandy National Hospital

    NOT_YET_RECRUITING

    Kandy, 20000, Sri Lanka

  • Kothalawala Defence University Hospital

    NOT_YET_RECRUITING

    Werahera, 10290, Sri Lanka

  • Kurunegala Teaching Hospital

    NOT_YET_RECRUITING

    Kurunegala, 60000, Sri Lanka

  • MGM Medical Care and Hospital

    ACTIVE_NOT_RECRUITING

    Sambhajinagar, Maharashtra, 431003, India

  • MS Ramaiah Medical College and Hospitals

    ACTIVE_NOT_RECRUITING

    Bangalore, Karnataka, 560054, India

  • Manchester University NHS Foundation Trust

    NOT_YET_RECRUITING

    Manchester, M13 9WL, United Kingdom

    Contact Email: •••••@•••••

  • Manipal Hospital

    ACTIVE_NOT_RECRUITING

    Pune, Maharashtra, 411045, India

  • Max Super Speciality Hospital

    ACTIVE_NOT_RECRUITING

    Patparganj, National Capital Territory of Delhi, 110092, India

  • Mazumdar Shah Medical Center

    ACTIVE_NOT_RECRUITING

    Bangalore, Karnataka, 560099, India

  • Muljibhai Patel Urological Hospital

    ACTIVE_NOT_RECRUITING

    Nadiād, Gujarat, 387003, India

  • NRS Medical College and Hospital Kolkata

    ACTIVE_NOT_RECRUITING

    Kolkata, West Bengal, 700014, India

  • National Hospital of Sri Lanka

    NOT_YET_RECRUITING

    Colombo, 00700, Sri Lanka

  • Nephrology Associates of Northern Illinois and Indiana (NANI)

    RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Nizam's Institute of Medical Sciences

    ACTIVE_NOT_RECRUITING

    Hyderabad, Telangana, 500082, India

  • Nutema Hospital

    ACTIVE_NOT_RECRUITING

    Meerut, Uttar Pradesh, 250002, India

  • Osmania General Hospital

    ACTIVE_NOT_RECRUITING

    Hyderabad, Telangana, 500012, India

  • Prolato Clinical Research Center

    RECRUITING

    Houston, Texas, 77054, United States

  • Pusan National University Hospital

    RECRUITING

    Busan, 49241, South Korea

  • Royal Derby Hospital

    RECRUITING

    Derby, DE22 3NE, United Kingdom

    Contact Email: •••••@•••••

  • SMS Medical College and Hospital

    ACTIVE_NOT_RECRUITING

    Jaipur, Rajasthan, 302004, India

  • SUM Hospital

    ACTIVE_NOT_RECRUITING

    Bhubaneswar, Odisha, 751029, India

  • Salford Royal NHS Foundation Trust

    NOT_YET_RECRUITING

    Salford, M6 8HD, United Kingdom

    Contact Email: •••••@•••••

  • Samsung Medical Center

    RECRUITING

    Soeul, 06351, South Korea

  • Sanjay Gandhi Post Graduate Institute of Medical Sciences

    ACTIVE_NOT_RECRUITING

    Lucknow, Uttar Pradesh, 226014, India

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam-si, 13620, South Korea

  • Severance Hospital - Yonsei Cancer Center

    RECRUITING

    Seoul, 03722, South Korea

  • Shri Guru Ram Rai Institute of Medical and Health Sciences

    ACTIVE_NOT_RECRUITING

    Dehradun, Uttarakhand, 248001, India

  • Sir Ganga Ram Hospital

    ACTIVE_NOT_RECRUITING

    New Delhi, National Capital Territory of Delhi, 110060, India

  • Sunway Medical Centre

    RECRUITING

    Petaling Jaya, Selangor, 47500, Malaysia

  • University Malaya Medical Centre

    RECRUITING

    Kuala Lumpur, Kuala Lumpur, 50603, Malaysia

  • Western Health Sunshine Hospital

    RECRUITING

    St Albans, Victoria, 3021, Australia

    Contact Email: •••••@•••••

  • Westmead Hospital

    RECRUITING

    Westmead, New South Wales, 2145, Australia

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.